# US 2008/0188379 A1 · Ptu compounds for promoting the in vitro culture of (highly pigmented) melanocytes

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0188379 A1
- Document ID: US20080188379A1
- Status: Published application
- Kind: A1
- Application number: 11/948,558
- Filed: 2007-11-30
- Published: 2008-08-07
- Earliest claimed: 2004-11-04
- Assignees: L'oreal
- Inventors: Marcelle REGNIER; Claire Tremblaye
- Web page: https://patentgrep.com/patent/US20080188379A1

## CPC

- A61K 35/36: Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells (islets of Langerhans A61K35/39)
- C12N 5/0626: {Melanocytes}
- C12N 2500/30: Organic components
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

A method for promoting the in vitro multiplication of human melanocytes and/or the freezing thereof, notably human melanocytes obtained from individuals of phototype IV, V or VI or from hyperpigmentary lesions entails introducing into a culture of same, a thus effective amount of at least one 1-phenyl-3-(2-thiazolyl)-2-thiourea (PTU) compound or PTU analogue or PTU mimetic selected from the group consisting of vitamin C, arbutin, hydroquinone, kojic acid or acid or ester derivative thereof, ellagic acid, aminophenol derivative, procysteine or derivative thereof, niacinamide, isothiocyanate, thiocyanate, lucinol and mixtures thereof; also provided thereby can be melanocyte libraries, co-cultures and reconstructed epidermides and/or reconstructed skin that are highly pigmented which are useful for the study of pigmentation disorders, for the screening of cosmetic or dermatological active agents, or for the treatment of skin lesions, in particular in individuals with a high phototype.

## Claims

### Claim 1

A method for promoting the in vitro multiplication of human melanocytes, comprising introducing into a culture of same, a thus effective amount of at least one 1-phenyl-3-(2-thiazolyl)-2-thiourea (PTU) compound or PTU analogue or PTU mimetic, said PTO mimetic being selected from the group consisting of vitamin C, arbutin, hydroquinone, kojic acid or acid or ester derivative thereof, ellagic acid, aminophenol derivative, procysteine or derivative thereof, niacinamide, isothiocyanate, thiocyanate, lucinol, and mixtures thereof, said PTU analogue being selected from the group consisting of a thiourea, a phenyl monoxide or dioxide, or a compound of formula (I):
wherein:
X is a hydrogen atom or a linear or branched C1-C4 alkyl radical or a halogen or a cyano group or a radical —OR′ or COOR′ in which R′ is a hydrogen atom or a C1-C4 alkyl radical, and
R is a hydrogen atom or an aromatic group that is unsubstituted or substituted with groups equivalent to X.

### Claim 2 (depends on 1)

The method as defined by claim 1, said human melanocytes being obtained from individuals of phototype IV, V or VI or from hyperpigmentary lesions.

### Claim 3 (depends on 1)

The method as defined by claim 1, said melanocytes, for a given phototype, being obtained from one or more individuals of the same ethnic origin or of different ethnic origins.

### Claim 4 (depends on 3)

The method as defined by claim 3, the sample of said melanocytes being obtained from the same anatomical site.

### Claim 5 (depends on 1)

The method as defined by claim 1, wherein the amount of PTU, PTU analogue or PTU mimetic present in the in vitro culture is provided according to following steps:
a) applying PTU, a PTU analogue or a PTU mimetic to melanocytes in culture, in various amounts;
b) evaluating the cytotoxicity of the various amounts of said PTU, PTU analogue or PTU mimetic on the melanocytes in culture by determining the percentage of cells that adhere to the culture support compared with untreated melanocytes and selecting the amounts for which the percentage of cells that adhere to the culture support is greater than or equal to 60%;
c) evaluating the effectiveness of the non-cytotoxic amounts of said PTU, PTU analogue or PTU mimetic selected in b), on the proliferation of melanocytes in culture, by quantifying the number of cells obtained after each passage compared with untreated melanocytes, and selecting the amounts of PTU, PTU analogue or PTU mimetic for which an increase in the multiplication of said melanocytes by a factor of 2 to 10 is obtained, compared with untreated melanocytes.

### Claim 6 (depends on 5)

The method as defined by claim 5, wherein the amount of PTU, PTU analogue, or PTU mimetic contacted with the human melanocytes before freezing, increases the percentage viability of said melanocytes, after thawing and re-culturing, by a factor of 10 to 20, compared with the percentage viability of untreated human melanocytes.

### Claim 7 (depends on 5)

The method as defined by claim 5, wherein the amount of PTU, PTU analogue, or PTU mimetic ranges from IC50/1.5 to IC50/10.

### Claim 8

A method for preparing human melanocyte cultures or human melanocyte libraries comprising introducing therein prior to or during a multiplication step a melanocye multiplication promoting effective amount of at least one 1-phenyl-3-(2-thiazolyl)-2-thiourea (PTU) compound or PTU analogue or PTU mimetic, said PTU mimetic being selected from the group consisting of vitamin C, arbutin, hydroquinone, kojic acid or acid or ester derivative thereof, ellagic acid, aminophenol derivative, procysteine or derivative thereof, niacinamide, isothiocyanate, thiocyanate, lucinol, and mixtures thereof, said PTU analogue being selected from the group consisting of a thiourea, a phenyl monoxide or dioxide, or a compound of formula (I):
wherein:
X is a hydrogen atom or a linear or branched C1-C4 alkyl radical or a halogen or a cyano group or a radical —OR′ or COOR′ in which R′ is a hydrogen atom or a C1-C4 alkyl radical, and
R is a hydrogen atom or an aromatic group that is unsubstituted or substituted with groups equivalent to X.

### Claim 9 (depends on 8)

The method as defined by claim 8, comprising preparing primary or secondary melanocyte cultures or libraries.

### Claim 10

A method for preparing co-cultures comprising at least melanocytes and keratinocytes, said method comprising incorporating therein human melanocytes multiplied in the presence of a melanocyte multiplication promoting effective amount of at least one 1-phenyl-3-(2-thiazolyl)-2-thiourea (PTU) compound or PTU analogue or PTU mimetic, said PTU mimetic being selected from the group consisting of vitamin C, arbutin, hydroquinone, kojic acid or acid or ester derivative thereof, ellagic acid, aminophenol derivative, procysteine or derivative thereof, niacinamide, isothiocyanate, thiocyanate, lucinol, and mixtures thereof, said PTU analogue being selected from the group consisting of a thiourea, a phenyl monoxide or dioxide, or a compound of formula (I):
wherein:
X is a hydrogen atom or a linear or branched C1-C4 alkyl radical or a halogen or a cyano group or a radical —OR′ or COOR′ in which R′ is a hydrogen atom or a C1-C4 alkyl radical, and
R is a hydrogen atom or an aromatic group that is unsubstituted or substituted with groups equivalent to X.

### Claim 11 (depends on 1)

The method as defined by claim 1, comprising introducing into said culture a thus effective amount of a PTU mimetic.

### Claim 12

A human melanocyte culture or a human melanocyte library, comprising melanocytes multiplied in the presence of a melanocyte multiplication promoting effective amount of at least one 1-phenyl-3-(2-thiazolyl)-2-thiourea (PTU) compound or PTU analogue or PTU mimetic, said PTU mimetic being selected from the group consisting of vitamin C, arbutin, hydroquinone, kojic acid or acid or ester derivative thereof, ellagic acid, aminophenol derivative, procysteine or derivative thereof, niacinamide, isothiocyanate, thiocyanate, lucinol, and mixtures thereof, said PTU analogue being selected from the group consisting of a thiourea, a phenyl monoxide or dioxide, or a compound of formula (I):
wherein:
X is a hydrogen atom or a linear or branched C1-C4 alkyl radical or a halogen or a cyano group or a radical —OR′ or COOR′ in which R′ is a hydrogen atom or a C1-C4 alkyl radical, and
R is a hydrogen atom or an aromatic group that is unsubstituted or substituted with groups equivalent to X and thereafter optionally freezing same.

### Claim 13 (depends on 12)

The human melanocyte culture or human melanocyte library as defined by claim 12, said melanocytes having been twice multiplied and twice frozen.

### Claim 14

A co-culture containing at least melanocytes and keratinocytes, comprising human melanocytes multiplied in the presence of a melanocyte multiplication promoting effective amount of at least one 1-phenyl-3-(2-thiazolyl)-2-thiourea (PTU) compound or PTU analogue or PTU mimetic, said PTU mimetic being selected from the group consisting of vitamin C, arbutin, hydroquinone, kojic acid or acid or ester derivative thereof, ellagic acid, aminophenol derivative, procysteine or derivative thereof, niacinamide, isothiocyanate, thiocyanate, lucinol, and mixtures thereof, said PTU analogue being selected from the group consisting of a thiourea, a phenyl monoxide or dioxide, or a compound of formula (I):
wherein:
X is a hydrogen atom or a linear or branched C1-C4 alkyl radical or a halogen or a cyano group or a radical —OR′ or COOR′ in which R′ is a hydrogen atom or a C1-C4 alkyl radical, and
R is a hydrogen atom or an aromatic group that is unsubstituted or substituted with groups equivalent to X.

### Claim 15

A method for promoting the in vitro multiplication of human melanocytes, comprising introducing into a culture of same, a thus effective amount of 1-phenyl-3-(2-thiazolyl)-2-thiourea.

### Claim 16 (depends on 15)

The method as defined by claim 15, said human melanocytes being obtained from individuals of phototype IV, V or VI or from hyperpigmentary lesions.

### Claim 17 (depends on 15)

The method as defined by claim 15, said melanocytes, for a given phototype, being obtained from one or more individuals of the same ethnic origin or of different ethnic origins.

### Claim 18 (depends on 17)

The method as defined by claim 17, the sample of said melanocytes being obtained from the same anatomical site.

### Claim 19 (depends on 15)

The method as defined by claim 15, wherein the amount of 1-phenyl-3-(2-thiazolyl)-2-thiourea present in the in vitro culture is provided according to following steps:
a) applying 1-phenyl-3-(2-thiazolyl)-2-thiourea to melanocytes in culture, in varying amounts ranging from 2 μm to 50 μm or 100 μm;
b) evaluating the cytotoxicity of the various amounts of 1-phenyl-3-(2-thiazolyl)-2-thiourea on the melanocytes in culture by determining the percentage of cells that adhere to the culture support compared with untreated melanocytes and selecting the amounts for which the percentage of cells that adhere to the culture support is greater than or equal to 60%;
c) evaluating the effectiveness of the non-cytotoxic amounts of 1-phenyl-3-(2-thiazolyl)-2-thiourea selected in b), on the proliferation of melanocytes in culture, by quantifying the number of cells obtained after each passage compared with untreated melanocytes, and selecting the amounts of 1-phenyl-3-(2-thiazolyl)-2-thiourea for which an increase in the multiplication of said melanocytes by a factor of 2 to 10 is obtained, compared with untreated melanocytes.

### Claim 20 (depends on 19)

The method as defined by claim 19, wherein the amount of 1-phenyl-3-(2-thiazolyl)-2-thiourea contacted with the human melanocytes before freezing, increases the percentage viability of said melanocytes, after thawing and re-culturing, by a factor of 10 to 20, compared with the percentage viability of untreated human melanocytes.

### Claim 21 (depends on 19)

The method as defined by claim 19, wherein the amount of 1-phenyl-3-(2-thiazolyl)-2-thiourea ranges from IC50/1.5 to IC50/10.

### Claim 22 (depends on 15)

The method as defined by claim 15, wherein the 1-phenyl-3-(2-thiazolyl)-2-thiourea is present in the in vitro culture in an effective amount ranging from 2 μM to 40 μM.

### Claim 23

A method for preparing human melanocyte cultures or human melanocyte libraries, comprising introducing therein, prior to or during a multiplication step, a melanocyte multiplication promoting effective amount of 1-phenyl-3-(2-thiazolyl)-2-thiourea.

### Claim 24 (depends on 23)

The method as defined by claim 23, comprising preparing primary or secondary melanocyte cultures or libraries.

### Claim 25

A method for preparing co-cultures comprising at least melanocytes and keratinocytes, said method comprising incorporating therein human melanocytes multiplied in the presence of a melanocyte multiplication promoting effective amount of 1-phenyl-3-(2-thiazolyl)-2-thiourea.

### Claim 26

A human melanocyte culture or a human melanocyte library, comprising melanocytes multiplied in the presence of a melanocyte multiplication promoting effective amount of 1-phenyl-3-(2-thiazolyl)-2-thiourea, and thereafter optionally freezing same.

### Claim 27 (depends on 26)

The human melanocyte culture or human melanocyte library as defined by claim 26, said melanocytes having been twice multiplied and twice frozen.

### Claim 28

A kit for producing a culture or a library of human melanocytes obtained from individuals of phototype IV, V or VI or from hyperpigmentary lesions, comprising (i) a preparation of human melanocytes obtained from individuals of phototype IV, V or VI or from hyperpigmentary lesions, and (ii) a culture medium for melanocytes supplemented with an amount of 1-phenyl-3-(2-thiazolyl)-2-thiourea ranging from 2 to 40 μM.

### Claim 29

A co-culture containing at least melanocytes and keratinocytes, comprising human melanocytes multiplied in the presence of a melanocyte multiplication promoting effective amount of 1-phenyl-3-(2-thiazolyl)-2-thiourea.
